Vigil Neuroscience, Inc. (VIGL)
NASDAQ: VIGL · Real-Time Price · USD
3.000
-0.050 (-1.64%)
Nov 21, 2024, 4:00 PM EST - Market closed
Vigil Neuroscience Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -82.6 | -82.64 | -68.31 | -43.28 | -57.09 |
Depreciation & Amortization | 0.45 | 0.4 | 0.08 | 0.03 | - |
Asset Writedown & Restructuring Costs | - | - | - | - | 41.85 |
Loss (Gain) From Sale of Investments | -0.97 | -1.49 | - | - | - |
Stock-Based Compensation | 10.04 | 8.9 | 5.48 | 2.09 | 0.52 |
Other Operating Activities | 1.39 | 1.36 | 0.93 | 1.18 | 2.66 |
Change in Accounts Payable | -0.44 | 0.01 | -2.48 | 2.35 | 2.21 |
Change in Other Net Operating Assets | 3.52 | 3.09 | -0.85 | -1.71 | -0.51 |
Operating Cash Flow | -48.59 | -70.36 | -65.15 | -39.35 | -10.36 |
Capital Expenditures | -0.02 | -0.67 | -0.92 | -0.2 | - |
Sale (Purchase) of Intangibles | - | - | - | - | -1 |
Investment in Securities | 11.61 | -64.46 | - | - | - |
Investing Cash Flow | 11.59 | -65.14 | -0.92 | -0.2 | -1 |
Total Debt Issued | - | - | - | - | 10 |
Long-Term Debt Repaid | - | -0.02 | -0.04 | -0.04 | - |
Net Debt Issued (Repaid) | - | -0.02 | -0.04 | -0.04 | 10 |
Issuance of Common Stock | 5.3 | 0.91 | 140.62 | 0.04 | 0 |
Other Financing Activities | - | - | 20.68 | -1.89 | - |
Financing Cash Flow | 25.11 | 0.89 | 161.26 | 107.75 | 59.66 |
Net Cash Flow | -11.9 | -134.61 | 95.19 | 68.2 | 48.3 |
Free Cash Flow | -48.61 | -71.04 | -66.07 | -39.55 | -10.36 |
Free Cash Flow Per Share | -1.22 | -1.84 | -2.09 | -25.82 | -7.68 |
Levered Free Cash Flow | -20.72 | -40.06 | -41.43 | -22.5 | - |
Unlevered Free Cash Flow | -20.72 | -40.06 | -41.43 | -22.5 | - |
Change in Net Working Capital | -24.06 | -6.85 | 3.01 | -2.1 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.